112 STAT. 2681-685 PUBLIC LAW 105-277—OCT. 21, 1998 (v) a review of the research agenda of the Counter- Drug Technology Assessment Center to reduce the availabihty and abuse of drugs; and (F) an assessment of private sector initiatives and cooperative efforts between the Federal Government and State and local governments for drug control. (2) SUBMISSION OF REVISED STRATEGY. —The President may submit to Congress a revised National Drug Control Strategy that meets the requirements of this section— (A) at any time, upon a determination by the President, in consultation with the Director, that the National Drug Control Strategy in effect is not sufficiently effective; and (B) if a new President or Director takes office. (3) 1999 STRATEGY REPORT.— With respect to the Strategy report required to be submitted by this subsection on February 1, 1999, the President shall prepare the report using such information as is available for the period covered by the report. (c) PERFORMANCE MEASUREMENT SYSTEM.— (1) SENSE OF CONGRESS.—It is the sense of Congress that— (A) the targets described in subsection (a) are important to the reduction of overall drug use in the United States; (B) the President should seek to achieve those targets during the 5 years covered by the National Drug Control Strategy required to be submitted under subsection (a); (C) the purpose of such targets and the annual reports to Congress on the progress towards achieving the targets is to allow for the annual restructuring of appropriations by the Appropriations Committees and authorizing committees of jurisdiction of Congress to meet the goals described in this Act; (D) the performance measurement system developed by the Director described in this subsection is central to the National Drug Control Program targets, programs, and budget; (E) the Congress strongly endorses the performgrnice measurement system for establishing clear outcomes for reducing drug use nationwide during the next five years, and the linkage of this system to all agency drug control programs and budgets receiving funds scored as drug control agency funding. (2) SUBMISSION TO CONGRESS.— Not later than February 1, 1999, the Director shall submit to Congress a description of the national drug control performance measurement system, designed in consultation with affected National Drug Control Program agencies, that— (A) develops performance objectives, measures, and targets for each National Drug Control Strategy goal and objective; (B) revises performance objectives, measures, and targets, to conform with National Drug Control Program Agency budgets; (C) identifies major programs and activities of the National Drug Control Program agencies that support the goals and objectives of the National Drug Control Strategy;
�
